Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

SCHEDULE 13G
This Schedule 13G (this “Schedule 13G”) is being filed on behalf of Anson Funds Management LP (d/b/a Anson Group), a Texas
limited partnership, Anson Management GP LLC, a Texas limited liability company, Mr. Bruce R. Winson, the principal of Anson Funds
Management LP and Anson Management GP LLC, Anson Advisors Inc. (d/b/a Anson Funds), an Ontario, Canada corporation, Mr. Amin
Nathoo, a director of Anson Advisors Inc., and Mr. Moez Kassam, a director of Anson Advisors Inc., relating to Common shares, no par
value (the “Common Stock”), of Intellipharmaceutics International Inc., a Canadian corporation (the “Issuer”).
This Schedule 13G relates to Common Stock of the Issuer purchased by a private fund to which Anson Funds Management LP and
Anson Advisors Inc. serve as co-investment advisors (the “Fund”). Anson Funds Management LP and Anson Advisors Inc. serve as
co-investment advisors to the Fund and may direct the vote and disposition of the 2,916,666 shares of Common Stock held by the Fund. As
the general partner of Anson Funds Management LP, Anson Management GP LLC may direct the vote and disposition of the 2,916,666
shares of Common Stock held by the Fund. As the principal of Anson Fund Management LP and Anson Management GP LLC,
Mr. Winson may direct the vote and disposition of the 2,916,666 shares of Common Stock held by the Fund. As directors of Anson
Advisors Inc., Mr. Nathoo and Mr. Kassam may each direct the vote and disposition of the 2,916,666 shares of Common Stock held by the
Fund.